LU91293I2 - Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia - Google Patents

Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia

Info

Publication number: LU91293I2
Authority: LU; Luxembourg
Prior art keywords: cerenia; maropitant; salt; compound; pharmaceutically acceptable
Prior art date: 1991-05-31

Application number

LU91293C

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-31

Filing date

2006-12-06

Publication date

2007-02-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24845673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU91293(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-06 Application filed by Pfizer filed Critical Pfizer

2007-02-06 Publication of LU91293I2 publication Critical patent/LU91293I2/fr

Links

OMPCVMLFFSQFIX-CONSDPRKSA-N (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine Chemical compound COC1=CC=C(C(C)(C)C)C=C1CN[C@@H]1[C@H](C(C=2C=CC=CC=2)C=2C=CC=CC=2)N2CCC1CC2 OMPCVMLFFSQFIX-CONSDPRKSA-N 0.000 title 1
PGVSXRHFXJOMGW-YBZGWEFGSA-N (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine;2-hydroxypropane-1,2,3-tricarboxylic acid;hydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O.COC1=CC=C(C(C)(C)C)C=C1CN[C@@H]1[C@H](C(C=2C=CC=CC=2)C=2C=CC=CC=2)N2CCC1CC2 PGVSXRHFXJOMGW-YBZGWEFGSA-N 0.000 title 1
YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 title 1
229940069233 cerenia Drugs 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
229960002505 maropitant Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

LU91293C 1991-05-31 2006-12-06 Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia LU91293I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70840491A	1991-05-31	1991-05-31
PCT/US1992/003317 WO1992021677A1 (fr)	1991-05-31	1992-04-28	Derives de quinuclidine

Publications (1)

Publication Number	Publication Date
LU91293I2 true LU91293I2 (fr)	2007-02-06

Family

ID=24845673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU91293C LU91293I2 (fr)	1991-05-31	2006-12-06	Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia

Country Status (41)

Country	Link
US (3)	US5807867A (fr)
EP (1)	EP0587723B1 (fr)
JP (2)	JPH0733386B2 (fr)
KR (1)	KR100214905B1 (fr)
CN (1)	CN1048492C (fr)
AP (1)	AP299A (fr)
AT (1)	ATE135006T1 (fr)
AU (1)	AU657552B2 (fr)
BG (1)	BG61694B1 (fr)
BR (1)	BR9206073A (fr)
CA (1)	CA2102179C (fr)
CZ (1)	CZ281403B6 (fr)
DE (4)	DE9290063U1 (fr)
DK (1)	DK0587723T3 (fr)
EG (1)	EG19944A (fr)
ES (1)	ES2084361T3 (fr)
FI (1)	FI114475B (fr)
GR (1)	GR3019687T3 (fr)
GT (1)	GT199200028A (fr)
HU (1)	HU217548B (fr)
IE (1)	IE72473B1 (fr)
IL (1)	IL102008A (fr)
IS (1)	IS1611B (fr)
LU (1)	LU91293I2 (fr)
MA (1)	MA22539A1 (fr)
MX (1)	MX9202554A (fr)
NL (1)	NL300250I2 (fr)
NO (2)	NO302701B1 (fr)
NZ (2)	NZ270673A (fr)
OA (1)	OA09867A (fr)
PL (1)	PL171379B1 (fr)
PT (1)	PT100546B (fr)
RO (1)	RO110499B1 (fr)
RU (1)	RU2103269C1 (fr)
SK (1)	SK390692A3 (fr)
TW (1)	TW204349B (fr)
UA (1)	UA27776C2 (fr)
UY (1)	UY23422A1 (fr)
WO (1)	WO1992021677A1 (fr)
YU (1)	YU48995B (fr)
ZA (1)	ZA923942B (fr)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE9290063U1 (de) *	1991-05-31	1994-02-24	Pfizer Inc., New York, N.Y.	Chinuclidin-Derivate
BR9206161A (pt) *	1991-06-20	1995-10-31	Pfizer	Derivados fluoroalcoxibenzilamino de heterociclos contendo nitrogénio
EP1114823A3 (fr) *	1992-08-19	2001-07-18	Pfizer Inc.	Benzylamino azote substitue renfermant des heterocycles non aromatiques
US5886009A (en) *	1992-11-12	1999-03-23	Pfizer Inc.	Quinuclidine derivative as a substance P antagonist
US5344830A (en) *	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
JP2822274B2 (ja) *	1993-05-19	1998-11-11	ファイザー製薬株式会社	Ｐ物質拮抗剤としてのヘテロ原子置換アルキルベンジルアミノキヌクリジン類
IL109646A0 (en) *	1993-05-19	1994-08-26	Pfizer	Heteroatom substituted alkyl benzylamino-quinuclidines
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (fr) *	1993-11-17	1995-10-11	Pfizer	Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire.
EP0659409A3 (fr) *	1993-11-23	1995-08-09	Pfizer	Antagonistes de la substance P pour l'inhibition de l'angiogénése.
EP0655246A1 (fr) *	1993-11-30	1995-05-31	Pfizer Inc.	Antagonistes de la substance P pour le traitement des maladies causées par Helicobacter Pylori ou d'autres bacteries spirales, ureare-positives, gram-négatives
IL116249A (en) *	1994-12-12	2003-07-06	Pfizer	Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
PE8798A1 (es) *	1995-07-17	1998-03-02	Pfizer	Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
TW458774B (en)	1995-10-20	2001-10-11	Pfizer	Antiemetic pharmaceutical compositions
IL123740A0 (en) *	1997-03-28	1998-10-30	Pfizer	NK-1 receptor antagonists for the treatment of delayed emesis
NZ329807A (en) *	1997-04-23	2000-07-28	Pfizer	NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
CN1291099A (zh) *	1998-03-19	2001-04-11	武田药品工业株式会社	杂环化合物,其生产和用途
US6255320B1 (en) *	1999-06-01	2001-07-03	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
US6387925B1 (en) *	1999-06-01	2002-05-14	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6262067B1 (en) *	1999-06-22	2001-07-17	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
JP2001172178A (ja) *	1999-10-25	2001-06-26	Pfizer Prod Inc	偏頭痛治療用のｎｋ−１レセプターアンタゴニスト及びエレトリプタン
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
KR100885986B1 (ko)	1999-11-03	2009-03-03	에이엠알 테크놀로지, 인크.	노르에피네프린, 도파민 및 세로토닌의 재흡수를 방지하기위한 아릴 및 헤테로아릴 치환된테트라하이드로이소퀴놀린 및 이들의 용도
IL142810A0 (en) *	2000-05-03	2002-03-10	Pfizer Prod Inc	Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
CA2415532C (fr)	2000-07-11	2010-05-11	Albany Molecular Research, Inc.	Nouvelles tetrahydroisoquinolines 4-phenyl substituees et leur utilisation a des fins therapeutiques
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (fr) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Composition pour le traitement de la dépression et de l'anxieté contenant un antagoniste du recepteur NK-3 et un antagoniste du récepteur NK-1
CZ200434A3 (cs) *	2001-07-20	2005-02-16	Pfizer Products Inc.	Léčivo pro léčení abnormálního úzkosného chování u domácích zvířat a způsob screeningu zkoušené sloučeniny za účelem stanovení anxiolytické účinnosti u psů
US6686507B2 (en)	2002-03-06	2004-02-03	Pfizer Inc	Purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
GB0220581D0 (en) *	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
US6861526B2 (en) *	2002-10-16	2005-03-01	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
ZA200505733B (en) *	2003-01-21	2006-10-25	Yeda Res & Dev	COP 1 for treatment of inflammatory bowel diseases
WO2005045395A2 (fr) *	2003-10-27	2005-05-19	Meyer Donald W	Methode de detection de l'encephalopathie spongiforme bovine
EP1689721B1 (fr) *	2003-11-26	2010-07-14	Pfizer Products Inc.	Derives d'aminopyrazole en tant qu'inhibiteurs de la gsk-3
CA2554823A1 (fr) *	2004-01-30	2005-09-09	Pfizer Products Inc.	Antagonistes des recepteurs nk-1 pour ameliorer la recuperation consecutive a une anesthesie
LT1713504T (lt) *	2004-01-30	2017-09-11	Zoetis Services Llc	Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
BRPI0507334A (pt)	2004-02-02	2007-07-03	Pfizer Prod Inc	processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina
KR101389246B1 (ko)	2004-07-15	2014-04-24	브리스톨-마이어스스퀴브컴파니	아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및 이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
EP1888050B1 (fr)	2005-05-17	2012-03-21	Merck Sharp & Dohme Ltd.	Acide cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl) cyclohexanepropanoique pour le traitement du cancer
ZA200800440B (en)	2005-07-15	2009-12-30	Amr Technology Inc	Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US8293900B2 (en)	2005-09-29	2012-10-23	Merck Sharp & Dohme Corp	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
EP2698157B1 (fr)	2006-09-22	2015-05-20	Merck Sharp & Dohme Corp.	Procédé de traitement utilisant des inhibiteurs de synthèse d'acide gras
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CN101190330A (zh)	2006-11-30	2008-06-04	深圳市鼎兴生物医药技术开发有限公司	胆碱酯酶在拮抗速激肽药物中的应用
EP2805945B1 (fr)	2007-01-10	2019-04-03	MSD Italia S.r.l.	Indazoles substitués d'amide en tant qu'inhibiteurs PARP de poly(ADP-ribose)polymérase
JP2010516734A (ja)	2007-01-24	2010-05-20	グラクソグループリミテッド	３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジンまたはｒ（−）−２，４−ジアミノ−５−（２，３−ジクロロフェニル）−６−フルオロメチルピリミジンを含む医薬組成物
US8106086B2 (en)	2007-04-02	2012-01-31	Msd K.K.	Indoledione derivative
US8389553B2 (en)	2007-06-27	2013-03-05	Merck Sharp & Dohme Corp.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
KR20100126467A (ko)	2008-03-03	2010-12-01	타이거 파마테크	티로신 키나아제 억제제
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
CN102638982B (zh)	2009-05-12	2015-07-08	百时美施贵宝公司	(S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
EP2429295B1 (fr)	2009-05-12	2013-12-25	Albany Molecular Research, Inc.	Aryle, hétéroaryle et tétrahydroisoquinolines à hétérocycle substitué et leur utilisation
KR101830447B1 (ko)	2009-05-12	2018-02-20	알바니 몰레큘라 리써치, 인크.	7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도
EP2488028B1 (fr)	2009-10-14	2020-08-19	Merck Sharp & Dohme Corp.	Pipéridines substituées qui accroissent l'activité de p53 et utilisations de ces composés
WO2011163330A1 (fr)	2010-06-24	2011-12-29	Merck Sharp & Dohme Corp.	Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk
CN107090456B (zh)	2010-08-02	2022-01-18	瑟纳治疗公司	使用短干扰核酸的RNA干扰介导的联蛋白（钙粘蛋白关联蛋白质），β1基因表达的抑制
JP2013537423A (ja)	2010-08-17	2013-10-03	メルク・シャープ・エンド・ドーム・コーポレイション	低分子干渉核酸（ｓｉＮＡ）を用いたＢ型肝炎ウイルス（ＨＢＶ）遺伝子発現のＲＮＡ干渉媒介性阻害
US8883801B2 (en)	2010-08-23	2014-11-11	Merck Sharp & Dohme Corp.	Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
WO2012030685A2 (fr)	2010-09-01	2012-03-08	Schering Corporation	Dérivés d'indazole utilisables en tant qu'inhibiteurs de la voie erk
EP2615916B1 (fr)	2010-09-16	2017-01-04	Merck Sharp & Dohme Corp.	Dérivés condensés de pyrazole utilisés comme nouveaux inhibiteurs erk
DK2632472T3 (en)	2010-10-29	2018-03-19	Sirna Therapeutics Inc	RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA)
WO2012087772A1 (fr)	2010-12-21	2012-06-28	Schering Corporation	Dérivés d'indazole utiles en tant qu'inhibiteurs de erk
EP2699568A1 (fr)	2011-04-21	2014-02-26	Piramal Enterprises Limited	Forme cristalline d'un sel d'un dérivé de morpholinosulfonylindole et son procédé de préparation
DK2729147T3 (en)	2011-07-04	2017-12-18	Irbm - Science Park S P A	NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF CORNOVA
WO2013063214A1 (fr)	2011-10-27	2013-05-02	Merck Sharp & Dohme Corp.	Nouveaux composés qui sont des inhibiteurs d'erk
EP2844261B1 (fr)	2012-05-02	2018-10-17	Sirna Therapeutics, Inc.	Compositions de petit acide nucléique interférent (sina)
CN105050598B (zh)	2012-09-28	2018-04-27	默沙东公司	作为erk抑制剂的新型化合物
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
RS56680B1 (sr)	2012-11-28	2018-03-30	Merck Sharp & Dohme	Kompozicije i postupci za lečenje kancera
US8846657B2 (en)	2012-12-20	2014-09-30	Merck Sharp & Dohme Corp.	Substituted imidazopyridines as HDM2 inhibitors
WO2014120748A1 (fr)	2013-01-30	2014-08-07	Merck Sharp & Dohme Corp.	Purines 2,6,7,8-substituées utilisées en tant qu'inhibiteurs de hdm2
EP3041938A1 (fr)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Polynucléotides circulaires
US10975084B2 (en)	2016-10-12	2021-04-13	Merck Sharp & Dohme Corp.	KDM5 inhibitors
IL312486B2 (en)	2017-04-10	2025-05-01	Chase Therapeutics Corp	NK1 antagonist combination and method for treating synucleinopathies
CN106977512B (zh) *	2017-05-04	2019-01-01	海门慧聚药业有限公司	制备马罗匹坦游离碱的方法
JP7158425B2 (ja)	2017-06-30	2022-10-21	チェイスセラピューティクスコーポレイション	Ｎｋ－１アンタゴニスト組成物およびうつ病の処置における使用法
US11098059B2 (en)	2017-11-08	2021-08-24	Merck Sharp & Dohme Corp.	PRMT5 inhibitors
EP3706742B1 (fr)	2017-11-08	2023-03-15	Merck Sharp & Dohme LLC	Inhibiteurs de prmt5
US20210015834A1 (en)	2018-02-26	2021-01-21	Ospedale San Raffaele S.R.L.	Nk-1 antagonists for use in the treatment of ocular pain
KR102102109B1 (ko) *	2018-07-10	2020-04-20	성균관대학교산학협력단	N-벤즈히드릴 퀴뉴클리딘 유도체를 포함하는 나트륨 누출 채널 억제용 조성물
EP3833668B1 (fr)	2018-08-07	2025-03-19	Merck Sharp & Dohme LLC	Inhibiteurs de prmt5
CA3108388A1 (fr)	2018-08-07	2020-02-13	Merck Sharp & Dohme Corp.	Inhibiteurs de prmt5
EP3833667B1 (fr)	2018-08-07	2024-03-13	Merck Sharp & Dohme LLC	Inhibiteurs de prmt5
EP4117673A1 (fr)	2020-03-11	2023-01-18	Ospedale San Raffaele S.r.l.	Traitement d'une déficience en cellules souches
AT527172A1 (de)	2023-04-25	2024-11-15	Vetviva Richter Gmbh	Maropitantformulierung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990005525A1 (fr) *	1988-11-23	1990-05-31	Pfizer Inc.	Derives de quinuclidine en tant qu'antagonsites de substance p
EP0532527B1 (fr) *	1990-06-01	1994-11-09	Pfizer Inc.	Quinuclidines de 3-amino-2-aryle, procede relatif a leur preparation et compositions pharmaceutiques les contenant
DE4026743A1 (de) *	1990-08-24	1992-02-27	Teves Gmbh Alfred	Blockiergeschuetzte bremsanlage fuer kraftfahrzeuge
US5716965A (en) *	1991-05-22	1998-02-10	Pfizer Inc.	Substituted 3-aminoquinuclidines
DE9290063U1 (de) *	1991-05-31	1994-02-24	Pfizer Inc., New York, N.Y.	Chinuclidin-Derivate
ATE195867T1 (de) *	1991-09-20	2000-09-15	Glaxo Group Ltd	Neue medizinische indikation für tachykinin- antagonisten
GB9218334D0 (en) *	1992-08-28	1992-10-14	Ici Plc	Heterocyclic compounds
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0655246A1 (fr) *	1993-11-30	1995-05-31	Pfizer Inc.	Antagonistes de la substance P pour le traitement des maladies causées par Helicobacter Pylori ou d'autres bacteries spirales, ureare-positives, gram-négatives
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
ATE194342T1 (de) *	1996-01-19	2000-07-15	Lonza Ag	Verfahren zur herstellung von optisch aktivem 3- chinuclidinol
US5990125A (en) *	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer

1992
- 1992-04-28 DE DE9290063U patent/DE9290063U1/de not_active Expired - Lifetime
- 1992-04-28 US US08/211,120 patent/US5807867A/en not_active Expired - Lifetime
- 1992-04-28 ES ES92912601T patent/ES2084361T3/es not_active Expired - Lifetime
- 1992-04-28 AU AU19901/92A patent/AU657552B2/en not_active Expired
- 1992-04-28 DE DE200612000066 patent/DE122006000066I2/de active Active
- 1992-04-28 UA UA93004096A patent/UA27776C2/uk unknown
- 1992-04-28 CA CA002102179A patent/CA2102179C/fr not_active Expired - Lifetime
- 1992-04-28 PL PL92301472A patent/PL171379B1/pl unknown
- 1992-04-28 RO RO93-01581A patent/RO110499B1/ro unknown
- 1992-04-28 BR BR9206073A patent/BR9206073A/pt not_active Application Discontinuation
- 1992-04-28 JP JP5500353A patent/JPH0733386B2/ja not_active Expired - Lifetime
- 1992-04-28 WO PCT/US1992/003317 patent/WO1992021677A1/fr not_active Ceased
- 1992-04-28 HU HU9303393A patent/HU217548B/hu active Protection Beyond IP Right Term
- 1992-04-28 DE DE69208877T patent/DE69208877T2/de not_active Expired - Lifetime
- 1992-04-28 DK DK92912601.9T patent/DK0587723T3/da active
- 1992-04-28 KR KR1019930703649A patent/KR100214905B1/ko not_active Expired - Lifetime
- 1992-04-28 EP EP92912601A patent/EP0587723B1/fr not_active Expired - Lifetime
- 1992-04-28 RU RU93058555A patent/RU2103269C1/ru active Protection Beyond IP Right Term
- 1992-04-28 CZ CS923906A patent/CZ281403B6/cs not_active IP Right Cessation
- 1992-04-28 AT AT92912601T patent/ATE135006T1/de active
- 1992-04-28 DE DE1992608877 patent/DE122006000066I1/de active Pending
- 1992-04-28 SK SK3906-92A patent/SK390692A3/sk not_active IP Right Cessation
- 1992-05-05 TW TW081103509A patent/TW204349B/zh not_active IP Right Cessation
- 1992-05-11 AP APAP/P/1992/000384A patent/AP299A/en active
- 1992-05-26 IL IL10200892A patent/IL102008A/en active Protection Beyond IP Right Term
- 1992-05-26 UY UY23422A patent/UY23422A1/es not_active IP Right Cessation
- 1992-05-29 MX MX9202554A patent/MX9202554A/es unknown
- 1992-05-29 YU YU56492A patent/YU48995B/sh unknown
- 1992-05-29 GT GT199200028A patent/GT199200028A/es unknown
- 1992-05-29 NZ NZ270673A patent/NZ270673A/en not_active IP Right Cessation
- 1992-05-29 ZA ZA923942A patent/ZA923942B/xx unknown
- 1992-05-29 NZ NZ242956A patent/NZ242956A/en not_active IP Right Cessation
- 1992-05-29 MA MA22826A patent/MA22539A1/fr unknown
- 1992-05-29 PT PT100546A patent/PT100546B/pt not_active IP Right Cessation
- 1992-05-29 IS IS3871A patent/IS1611B/is unknown
- 1992-05-30 EG EG28492A patent/EG19944A/xx active
- 1992-05-30 CN CN92104129A patent/CN1048492C/zh not_active Expired - Lifetime
- 1992-07-01 IE IE921729A patent/IE72473B1/en not_active IP Right Cessation
1993
- 1993-11-26 BG BG98248A patent/BG61694B1/bg unknown
- 1993-11-29 NO NO934312A patent/NO302701B1/no not_active IP Right Cessation
- 1993-11-29 FI FI935297A patent/FI114475B/fi not_active IP Right Cessation
- 1993-11-30 OA OA60442A patent/OA09867A/en unknown
1994
- 1994-10-05 JP JP6241456A patent/JP2645225B2/ja not_active Expired - Lifetime
1995
- 1995-01-24 US US08/377,552 patent/US6222038B1/en not_active Expired - Lifetime
1996
- 1996-04-19 GR GR960401066T patent/GR3019687T3/el unknown
1997
- 1997-04-30 US US08/846,909 patent/US5939433A/en not_active Expired - Lifetime
2006
- 2006-12-06 NL NL300250C patent/NL300250I2/nl unknown
- 2006-12-06 LU LU91293C patent/LU91293I2/fr unknown
2007
- 2007-03-09 NO NO2007003C patent/NO2007003I2/no unknown

Also Published As

Publication number	Publication date
TW204349B (fr)	1993-04-21
ATE135006T1 (de)	1996-03-15
HU217548B (hu)	2000-02-28
JPH06504292A (ja)	1994-05-19
NL300250I2 (nl)	2007-03-01
JP2645225B2 (ja)	1997-08-25
DE122006000066I1 (de)	2007-03-22
CZ281403B6 (cs)	1996-09-11
PT100546B (pt)	1999-12-31
US6222038B1 (en)	2001-04-24
NO302701B1 (no)	1998-04-14
FI935297A0 (fi)	1993-11-29
IE921729A1 (en)	1992-12-02
IE72473B1 (en)	1997-04-23
DK0587723T3 (da)	1996-04-01
YU56492A (sh)	1995-03-27
AP9200384A0 (en)	1992-07-31
US5939433A (en)	1999-08-17
NO2007003I2 (no)	2011-04-18
PT100546A (pt)	1993-08-31
RO110499B1 (ro)	1996-01-30
UA27776C2 (uk)	2000-10-16
BG98248A (bg)	1994-07-29
NZ270673A (en)	1997-07-27
EG19944A (en)	1997-02-27
RU2103269C1 (ru)	1998-01-27
EP0587723A1 (fr)	1994-03-23
HUT70151A (en)	1995-09-28
KR100214905B1 (ko)	1999-08-02
JPH07285965A (ja)	1995-10-31
NO934312D0 (no)	1993-11-29
YU48995B (sh)	2003-04-30
NZ242956A (en)	1995-06-27
SK278788B6 (sk)	1998-02-04
IL102008A0 (en)	1992-12-30
DE9290063U1 (de)	1994-02-24
GT199200028A (es)	1993-11-20
CN1048492C (zh)	2000-01-19
JPH0733386B2 (ja)	1995-04-12
NO934312L (no)	1993-11-29
CA2102179A1 (fr)	1992-12-01
CZ390692A3 (en)	1994-02-16
FI114475B (fi)	2004-10-29
AP299A (en)	1994-01-14
MA22539A1 (fr)	1992-12-31
GR3019687T3 (en)	1996-07-31
IL102008A (en)	1995-12-08
EP0587723B1 (fr)	1996-03-06
ZA923942B (en)	1993-11-29
AU657552B2 (en)	1995-03-16
CA2102179C (fr)	1998-10-27
AU1990192A (en)	1993-01-08
ES2084361T3 (es)	1996-05-01
DE69208877D1 (de)	1996-04-11
HU9303393D0 (en)	1994-03-28
NL300250I1 (nl)	2007-02-01
WO1992021677A1 (fr)	1992-12-10
MX9202554A (es)	1992-11-01
IS3871A (is)	1992-12-02
PL171379B1 (en)	1997-04-30
SK390692A3 (en)	1998-02-04
BR9206073A (pt)	1994-12-06
US5807867A (en)	1998-09-15
FI935297L (fi)	1993-11-29
NO2007003I1 (no)	2007-03-26
DE122006000066I2 (de)	2007-12-06
BG61694B1 (bg)	1998-03-31
DE69208877T2 (de)	1996-07-25
CN1067428A (zh)	1992-12-30
IS1611B (is)	1996-10-18
OA09867A (en)	1994-08-15
UY23422A1 (es)	1992-11-12

Publication	Publication Date	Title
LU91293I2 (fr)	2007-02-06	Maropitant ou un sel pharmaceutiquement acceptabled'un tel composé, y compris le sel de monohydrate de citrate. cerenia
DE59300018D1 (de)	1994-12-08	Fungizide Azolylmethyl-fluorcycloproplylderivate.
LU88842I2 (fr)	1997-01-27	Nebivolol optionnellement sous forme d'un sel ou d'un hydrate pharmaceutiquement acceptable en particulier hydroclorure de Nebivolol
AR244193A1 (es)	1993-10-29	Un procedimiento continuo para preparar 1,1,1-trifluoro-2,2-dicloroetano
USD272887S (en)	1984-03-06	Clip for game goal nets
GB9225131D0 (en)	1993-01-20	Fungicidal active compound combinations
EP1026162A4 (fr)	2001-01-17	Agent anti-rhumatismal
EP0649308A4 (fr)	1994-06-22	Prevention de l'hemolyse.
EP0575122A3 (en)	1994-05-25	Fungicidal (2-aryl-2-substituted) ethyl-1,2,4-triazoles
ATE120185T1 (de)	1995-04-15	Biozide verbindungen.
ZA91315B (en)	1991-11-27	Fungicidal active compound combinations
MX9207407A (es)	1993-06-01	Mejora de la biodisponibilidad de agentes terapeuticos proteoliticamente labiles.
ZA91314B (en)	1991-11-27	Fungicidal active compound combinations
ZA929405B (en)	1993-06-07	2-(Heteroaryloxyphenoxy) alkylsulfonates useful as herbicidal agents.
GB9122467D0 (en)	1991-12-04	Fungicidal compounds
USD277726S (en)	1985-02-26	Riser stabilizer for sprinkler system pipes
DE69016122D1 (de)	1995-03-02	Biozide Verbindungen.
IT8719166A0 (it)	1987-01-27	Procedimento per la preparazione di composti ad attivita' anti-ulcera.
DE69009894D1 (de)	1994-07-21	Biozide Azoxim-Verbindungen.
Cerridwen	1989	Paleoecology of Pleistocene Mollusca from the Ironshore Formation, Grand Cayman, BWI
FR2685163B1 (fr)	1994-10-28	Attache, notamment pour le palissage des vignes.
ZA929195B (en)	1993-05-24	2-(heteroaryloxyphenoxy) alkylsulfonates useful as herbicidal agents.
DE69009900D1 (de)	1994-07-21	Biozide Azoxim-Verbindungen.
GB9125589D0 (en)	1992-01-29	Fungicidal compounds
GB9112696D0 (en)	1991-07-31	Process for the preparation of biocidal compounds